Trial Profile
A Prospective, Non-Interventional Cohort Study of Approved Sofosbuvir-based Regimens in Patients in Mexico With Chronic Hepatitis C Virus Infection in Clinical Practice
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Oct 2018
Price :
$35
*
At a glance
- Drugs Sofosbuvir (Primary)
- Indications Hepatitis C
- Focus Adverse reactions
- Sponsors Gilead Sciences
- 28 Sep 2018 Status changed from active, no longer recruiting to completed.
- 09 Aug 2018 Planned End Date changed from 1 Jun 2018 to 1 Aug 2018.
- 09 Aug 2018 Planned primary completion date changed from 1 Jun 2018 to 1 Aug 2018.